Member Info for Uncanny

No thats what l expect but on the timing - no idea.

No idea as l’m not expecting anything yet, but..... 1. Worse case is a placing, but l can’t see that as we have money until Q3 by my estimates. 2. More LoI’ s signing with Asian based partners 3. Details of Euro and US LoI - the deal 4. 201 initial data in June / July 5. 201 analysis Q3 and details of next stage - possibly early stage deal? 6. SEEK RNS 401 monetary value @ 55.5% to VAL 7. More patents Etc, etc

What are you expecting Valju?

Also, we have money until Q3 so very unlikely IMHO of a fund raise when VAL know they have all their ducks lined up for 401 with cash upfront via SEEK.

They can’t as the IP is owned by VAL or with 401 SEEK and VAL own 55.5% of SEEK. That would be theft and criminal proceedings would follow.

Yes Wayne, is the official regulatory news (RNS) announcing two signed LoI’s with a US and Euro partner a lie?

Or invested / work for a competing oncology company or indeed are short or looking for a low entry point or just slightly deranged?!

Why on earth would they now consolidate when on the brink of commercialisation and soon to realise funding? Makes no sense except to put fear and doubt in shareholders minds. Shame on you. If its any consolation l’m in for another 2mn at the months end as VAL is now on the cusp of great things and l can’t see a price below 1p lasting much longer. Running out of time chaps IMHO!

So does that mean we can only have derampers and pessimists?

Hear hear Yoga! Sorry to hear your news and wholeheartedly agree with your comments. All the best to you. U.

Logansrun Yes, just a little more patience needed after getting this far after years of development. Show us the money VAL!

I agree Shirley, diplomacy not aggression is more constructive.

War chest for what exactly? TIA

Quite right Noise. 101 early days but shareholder value in 401 commercialisation (8 figure total package for SEEK and VAL) and 201 that gets the fluids boiling, so to speak! As you say, May could be an exciting month as investors position themselves for a repeat to December 2017. Why would we get all the hype on 201 pre-close on CTl/ll just to disappoint! Its funny how all the doomsayers come out of the woodworks when we get close to an epiphany for VAL in its fortunes. LTH’s have suffered by the dilution which is enviitablel, but thats the nature of junior bios until they get to fruition point. This why its worth waiting for news and the story to unfold: https://www.cnbc.com/2018/08/02/why-ronald-wayne-sold-his-10-percent-stake-in-apple-for-800-dollars.html

Noise CAR-T is a decade away as you say. Why do you think we suffer the daily barrage of de-ramping attackers on here and ADVFN? Because VAL’s compounds are a serious threat to various other small bios products because VAL are so close to commercialisation and this gives them brown underpants. LOL Hoping for more LoI for 401and extremely excited at the next 201 update.

If they sold 201 upfront, that would be a minimum nice 20 bagger! I hope they do tbh.

Dracula, l have averaged all the way down to 1.17p so feel any decent deal news will be a multiple of that IMHO, otherwise as long as the science remains positive at each update as it is now, l may just sit tight and let shareholder value shine through in due time.

Valju, whats on Tuesday?

Dracula A few points: 1. Have they sold? They may have but if we get another update soon we will see if they still declare their interest. If they had a holding l don’t reckon it would have been substantial anyway. 2. If they signed a NDA or became an insider, they simply couldn’t disclose anything to anyone

Just reading through the last research note from Align and their target price figures of 10.28p (6 times then) for 401 de-risked (negligible for 201) and 13 times when VAL201 is de-risked, hopefully when CTl/ll complete. With the last 6 month dilution this adjusts to 8.02p and 17.37p respectively. These were quite conservative calculations too. What is interesting in light of the US and Euro partner LOI’s, is that Align assume in their October 2018 DCF calculations: “To highlight the potential value offered from the VAL201 and VAL401 candidates we have prepared a ten-year discount cash flow analysis of each product, in both the US and European markets” Coincidental or Align were aware of the talks between US and Euro partners back when they released their research note 24th October 2018? Everyone recalls how infuriated Align were as shareholders, then met the BoD and then went very quiet! What did they gleam after probably signing an NDA or becoming an insider why they went from uber pessimist to super bullish? Like many of us, lMHO there are very positive things going on behind the scenes that we simply don’t know about nor are the BoD able to disclose due to NDA’s and the sensitivity of discussions in what is a very cut throat market place. Happy Easter all.